Virbac Corporation

Virbac Sa

Laboratoires Virbac

Friulchem Spa

Laboratories Virbac

Laboratoires Ardeval

Guy Derrieu

Bernard Raynier

Jean-Luc Pougnas

Christian Karst

Jean Pascal Marc

Giancarlo Mazzola

Luc Castelli

Claude Laruelle

Patricia Monginoux

Nathalie Delhom

Georges Bufala

Vincent Beuvry

Olivier Broussaud

Thierry Grenier

Thierry Gozlan

Bruno Roy

Carolin L Schumacher

Andre Aubert

David Corvaisier

The present invention concerns a solid, palatable composition and its preparation process which, relative to the total weight of the composition, comprises: The said solid composition is obtained by mixing the components, vaporising the fats, calibrating the dry, fluid granular material and compressing the granular material in a stock cube press.

Compositions for oral administration to animals, processes for obtaining the same and the uses thereof

The invention relates to a method for the production of a time-stable, solid appetizing composition and to the use thereof, said composition comprising at least one active substance which is introduced in the final production step, by adding same to the already formed mixture of other components at ambient temperature, without the use of water or heat. The composition is intended for use as a drug, a nutraceutical or a food supplement for oral administration to mammals, except humans, in particular for pets such as dogs, cats or horses. The stable solid composition is obtained by compressing the mixture using a press for compressing formulations having a high fat content.

Compositions for oral administration to animals, production methods thereof and uses of same

The invention relates to a chewable object for carnivorous pets. The inventive object () is provided with an elongated shape and comprises a chewable, edible and digestible substance. The invention is characterised in that the shape of the object () comprises at least two dihedrals (dd) having edges (aa) which essentially extend along the entire length of the object.

Edible, chewable object for carnivorous pets and method of controlling the hygiene of the oral cavity of said pets using one such object

The invention relates to a composition comprising revivable dehydrated micro-organisms. The invention is characterized in that it further comprises particles at least 50% of which have a mean diameter greater than 250 &#x3bc;m. The invention is applicable, in particular, to human or veterinary pharmaceuticals, to dietetics or to food products.

Method of preparation of compositions comprising dehydrated micro-organisms

The invention relates to a self-emulsifiable liquid composition intended to be diluted in an aqueous intermediate solution and then incorporated into the drinking water of livestock animals, and also to the use of such a composition. The invention is characterized in that the composition comprises at least&#x2014;between 1% and 12% by weight of the florfenicol active ingredient, relative to the total volume of the composition; &#x2014;at least 50% by weight, relative to the total volume of the composition (p/v), of a mixture of C8-C10 saturated polyglycosylated glycerides having an HLB (hydrophilic-lipophilic balance) of less than 16; and&#x2014;at least 5% by weight, relative to the total volume of the composition (p/v), of a surfactant.

Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock

Compositions comprising dehydrated micro-organisms, method for preparing same, and uses thereof

The present invention relates to the use, as active ingredient, of a 1-N-(halo-3-pyridylmethyl)-N-methylamino-1-alkylamino-2-nitroethylene derivative for preparing a veterinary pharmaceutical composition for topical application in the treatment of external parasites, in particular fleas, in domestic animals, in particular in dogs and cats, intended to be applied at least every 2 weeks.

Use of a 1-N-(halo-3-pyridylmethyl)-N-methylamino-1-alkylamino-2-nitroethylene derivative for preparing a topical veterinary pharmaceutical composition for combating external parasites

The present invention relates to a liquid pharmaceutical composition containing an N-phenylpyrazole derivative as active ingredient and alpha-(tetrahydrofuranyl)-omega-hydroxypoly(oxy-1,2-ethanediyl) as solvent for the treatment and/or prevention of infestations with fleas in domestic animals.

Pharmaceutical composition containing an N-phenylpyrazole derivative and glycofurol, use for the preparation of a topical veterinary medicament for combating fleas

The present invention relates to the use, as active ingredient, of a 1-N-(halo-3-pyridylmethyl)-N-methylamino-1-alkylamino-2-nitroethylene derivative for preparing a veterinary pharmaceutical composition for topical use in the treatment of external parasites, in particular fleas, in domestic animals, in particular in dogs and cats, intended to be applied at least every 2 weeks.

Derivative for preparing a topical veterinary pharmaceutical composition for combating external parasites

The invention relates to a liquid pharmaceutical composition that contains N-phenylpyrazole derivative as an active principle, benzyl alcohol, and an appropriately selected organic solvent, and to the use of such a composition for preparing a topically applied antiparasitic veterinary drug for preventing and/or treating flea infestation in pets, in particular, in dogs and cats.

Pharmaceutical composition containing an N-phenylpyrazole derivative, and use thereof for preparing a topical veterinary for flea control

Injectable compositions containing a liquid solvent free of solid polymers, anthelmintic agent(s)and hormonal growth promoter(s), where the anthelmintic agent(s) and the hormonal growth promoter(s) are dissolved in the polymer free solvent system. The present invention additionally relates to methods of promoting animal growth and inhibiting parasitic infection/infestation with these compositions, as well as methods of preparing such compositions.

Injectable anthelmintic compositions and methods for using same

Chondroitin sulphate and chitosan compositions for treating rheumatic disorders

The present invention relates to compositions which contain at least one cationic polymer and at least one active molecule contained in at least one micro or nanoparticulate vector, and their use for treating living or inert surfaces.

Compositions which contain at least one cationic polymer and at least one active molecule contained in at least one micro or nonopartculate vector, and their use for treating living or inert surfaces

Device designed to be carried by an animal and capable of controlled release of one or several active principles and, more particularly, one or several medicinal active principles to protect and/or treat this animal against possible pathologies, and capable of being used as a restraint for controlling and managing the animal. In one embodiment the device is used with a leash or lead fixed to the device. Method for making the device. The device comprises a first material for the controlled release of one or several active substances of polymer matrix type containing this active substance and a second material for providing it with mechanical resistance, the materials being closely bound within a single structure.

Growing community of inventors

Cagnes sur Mer, France

Guy Derrieu